Non-neuronal induction of immunoproteasome subunits in an ALS model: Possible mediation by cytokines

[1]  P. Cascio,et al.  Accumulation of human SOD1 and ubiquitinated deposits in the spinal cord of SOD1G93A mice during motor neuron disease progression correlates with a decrease of proteasome , 2005, Neurobiology of Disease.

[2]  A. Hill,et al.  Impaired Extracellular Secretion of Mutant Superoxide Dismutase 1 Associates with Neurotoxicity in Familial Amyotrophic Lateral Sclerosis , 2005, The Journal of Neuroscience.

[3]  J. Agar,et al.  Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis , 2004, Journal of neurochemistry.

[4]  A. Rivett,et al.  Proteasome function in antigen presentation: immunoproteasome complexes, Peptide production, and interactions with viral proteins. , 2004, Current protein & peptide science.

[5]  Isidro Ferrer,et al.  Proteasomal Expression, Induction of Immunoproteasome Subunits, and Local MHC Class I Presentation in Myofibrillar Myopathy and Inclusion Body Myositis , 2004, Journal of neuropathology and experimental neurology.

[6]  A. Bruce-Keller,et al.  Loss of an individual proteasome subunit alters motor function but not cognitive function or ambulation in mice , 2004, Neuroscience Letters.

[7]  Isidro Ferrer,et al.  Neuronal Induction of the Immunoproteasome in Huntington's Disease , 2003, The Journal of Neuroscience.

[8]  D. Borchelt,et al.  Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. , 2003, Human molecular genetics.

[9]  G. Demartino,et al.  Aggregate formation in the spinal cord of mutant SOD1 transgenic mice is reversible and mediated by proteasomes , 2003, Journal of neurochemistry.

[10]  Minh N. H. Nguyen,et al.  Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice , 2003, Science.

[11]  Scott Ferrell,et al.  Message and protein-level elevation of tumor necrosis factor α (TNFα) and TNFα-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis , 2003, Neurobiology of Disease.

[12]  A. Goldberg,et al.  The Caspase-like Sites of Proteasomes, Their Substrate Specificity, New Inhibitors and Substrates, and Allosteric Interactions with the Trypsin-like Sites* , 2003, Journal of Biological Chemistry.

[13]  Moonhee Lee,et al.  Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins , 2003, Journal of neurochemistry.

[14]  J. Pate,et al.  Expression and Regulation of Interferon γ-Inducible Proteasomal Subunits LMP7 and LMP10 in the Bovine Corpus Luteum1 , 2003 .

[15]  R. Takahashi,et al.  Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis , 2002, Journal of neurochemistry.

[16]  U. Krishnan,et al.  Disease Progression in a Transgenic Model of Familial Amyotrophic Lateral Sclerosis Is Dependent on Both Neuronal and Non-Neuronal Zinc Binding Proteins , 2002, The Journal of Neuroscience.

[17]  M. Beal,et al.  Mutated Human SOD1 Causes Dysfunction of Oxidative Phosphorylation in Mitochondria of Transgenic Mice* , 2002, The Journal of Biological Chemistry.

[18]  D. Borchelt,et al.  Fibrillar Inclusions and Motor Neuron Degeneration in Transgenic Mice Expressing Superoxide Dismutase 1 with a Disrupted Copper-Binding Site , 2002, Neurobiology of Disease.

[19]  K. Hensley,et al.  Temporal patterns of cytokine and apoptosis‐related gene expression in spinal cords of the G93A‐SOD1 mouse model of amyotrophic lateral sclerosis , 2002 .

[20]  Hermann-Georg Holzhütter,et al.  Assessment of proteasomal cleavage probabilities from kinetic analysis of time-dependent product formation. , 2002, Journal of molecular biology.

[21]  D. Borchelt,et al.  High Molecular Weight Complexes of Mutant Superoxide Dismutase 1: Age-Dependent and Tissue-Specific Accumulation , 2002, Neurobiology of Disease.

[22]  D. Price,et al.  Histological Evidence of Protein Aggregation in Mutant SOD1 Transgenic Mice and in Amyotrophic Lateral Sclerosis Neural Tissues , 2001, Neurobiology of Disease.

[23]  J. Elliott.  Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. , 2001, Brain research. Molecular brain research.

[24]  R. Kiessling,et al.  Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface. , 2001, Blood.

[25]  H. Rammensee,et al.  Discrete Cleavage Motifs of Constitutive and Immunoproteasomes Revealed by Quantitative Analysis of Cleavage Products , 2001, The Journal of experimental medicine.

[26]  M. Gurney,et al.  Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Slaughter,et al.  cDNA Cloning, Expression, and Functional Characterization of PI31, a Proline-rich Inhibitor of the Proteasome* , 2000, The Journal of Biological Chemistry.

[28]  J. Elliott,et al.  Metallothionein Expression Is Altered in a Transgenic Murine Model of Familial Amyotrophic Lateral Sclerosis , 2000, Experimental Neurology.

[29]  P. Kloetzel,et al.  Biochemical analysis of proteasomes from mouse microglia: Induction of immunoproteasomes by interferon‐γ and lipopolysaccharide , 2000, Glia.

[30]  C. Slaughter,et al.  The Proteasome, a Novel Protease Regulated by Multiple Mechanisms* , 1999, The Journal of Biological Chemistry.

[31]  S. Przedborski,et al.  Inducible Nitric Oxide Synthase Up‐Regulation in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis , 1999, Journal of neurochemistry.

[32]  L. Bruijn,et al.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. , 1998, Science.

[33]  R. Kohanski,et al.  Altered Properties of the Branched Chain Amino Acid-preferring Activity Contribute to Increased Cleavages after Branched Chain Residues by the “Immunoproteasome”* , 1998, The Journal of Biological Chemistry.

[34]  M. Gurney,et al.  Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS , 1998 .

[35]  C. Slaughter,et al.  Relative Functions of the α and β Subunits of the Proteasome Activator, PA28* , 1997, The Journal of Biological Chemistry.

[36]  K. Nakashima,et al.  Pathological characterization of astrocytic hyaline inclusions in familial amyotrophic lateral sclerosis. , 1997, The American journal of pathology.

[37]  D. Borchelt,et al.  ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions , 1997, Neuron.

[38]  D. Schiffer,et al.  Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis , 1996, Journal of the Neurological Sciences.

[39]  A. Goldberg,et al.  Proteasome Subunits X and Y Alter Peptidase Activities in Opposite Ways to the Interferon-γ-induced Subunits LMP2 and LMP7* , 1996, The Journal of Biological Chemistry.

[40]  W. Hung,et al.  Intense Superoxide Dismutase‐1 Immunoreactivity in Intracytoplasmic Hyaline Inclusions of Familial Amyotrophic Lateral Sclerosis with Posterior Column Involvement , 1996, Journal of neuropathology and experimental neurology.

[41]  Anita A. Strong,et al.  Identification, Purification, and Characterization of a PA700-dependent Activator of the Proteasome (*) , 1996, The Journal of Biological Chemistry.

[42]  D. Borchelt,et al.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.

[43]  M. Gurney,et al.  Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. , 1994, The American journal of pathology.

[44]  S. Tonegawa,et al.  Altered peptidase and viral-specific T cell response in LMP2 mutant mice. , 1994, Immunity.

[45]  M. Gurney,et al.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.

[46]  D. Troost,et al.  Neuronophagia in the motor cortex in amyotrophic lateral sclerosis , 1993, Neuropathology and applied neurobiology.

[47]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[48]  P. Thomas,et al.  Interferon gamma regulates accumulation of the proteasome activator PA28 and immunoproteasomes at nuclear PML bodies. , 2001, Journal of cell science.

[49]  R. Kopito,et al.  Impairment of the ubiquitin-proteasome system by protein aggregation. , 2001, Science.

[50]  D. Sarkar,et al.  Transforming growth factor-beta1 induces transforming growth factor-beta1 and transforming growth factor-beta receptor messenger RNAs and reduces complement C1qB messenger RNA in rat brain microglia. , 2000, Neuroscience.